Titan Trust 2024 I Disposes of DarioHealth Corp. Shares

Titan Trust 2024 I, a Delaware statutory trust, has filed an amendment to its Schedule 13G, indicating the disposition of all 2,499,618 shares of DarioHealth Corp. common stock during the three months ended September 30, 2025. These shares were acquired through the cashless exercise of a third warrant dated February 15, 2024. The filing also notes that the number of shares reflects a pre-20-to-1 reverse stock split implemented by DarioHealth Corp. on August 28, 2025. Titan Trust 2024 I now holds 0% of the issuer's common stock. The filing is made under Rule 13d-1(c) and includes certifications that the shares were not acquired for the purpose of influencing the control of the issuer.